Home »
Academic Articles »
R »
Generation of human induced pluripotent stem cell line MHHi040-A from a female Fabry disease patient carrying c.644A>G missense mutation
Generation of human induced pluripotent stem cell line MHHi040-A from a female Fabry disease patient carrying c.644A>G missense mutation
Carla Borisch
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany)
Nick Heise
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany)
Kristina Sonnenschein
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany)
Nataliya Di Donato
(Department of Human Genetics, Hannover Medical School, Hannover, Germany)
Anika Gietz
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany)
Theresa Buchegger
(Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany)
Malte Juchem
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany)
Nico Lachmann
(Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany; Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany)
Christian Bär
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany)
Thomas Thum
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany)
Jeannine Hoepfner
(Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Corresponding author at: Hannover Medical School, Institute of Molecular and Translational Therapeutic Strategies, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.)
Journal: Stem Cell Research
•
• Elsevier
• ISSN: 1873-5061
Abstract
Fabry disease (FD) is an X-linked, monogenic lysosomal storage disorder, caused by mutations in the GLA gene. GLA encodes the lysosomal hydrolase alpha-galactosidase A and enzyme deficiency leads to accumulation of its substrate globotriaosylceramide (Gb3), culminating in multisystemic symptoms. Here, we generated a human induced pluripotent stem cell line from a female FD patient, carrying a c.644A > G missense mutation. The hiPSCs showed a normal karyotype, typical stem cell morphology, expression of pluripotency markers and were capable of trilineage differentiation. Therefore, MHHi040-A represents a valuable resource for future FD studies, investigating both disease mechanisms as well as novel therapeutic strategies.
Carla Borisch, Nick Heise, Kristina Sonnenschein, et al. (2026). "Generation of human induced pluripotent stem cell line MHHi040-A from a female Fabry disease patient carrying c.644A>G missense mutation". Stem Cell Research. https://doi.org/10.1016/j.scr.2026.104064